BRUCE STARK: Open Payments
NPI 1902801301 · BURBANK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 46 payments from 20 companies in 2025. Trend: 2023 $1,262 · 2024 $528 · 2025 $957
Food & beverage: $957
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $168 |
| Indivior Inc. | 5 | $124 |
| Lundbeck LLC | 3 | $80 |
| Novo Nordisk Inc | 3 | $70 |
| Alkermes, Inc. | 2 | $69 |
| ABBVIE INC. | 3 | $53 |
| Gilead Sciences, Inc. | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Dexcom, Inc. | 1 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
Products named: RELISTOR, SUBLOCADE, REXULTI, VIVITROL, Kerendia, Ozempic, Dexcom G6 Transmitter, VRAYLAR.
Industry payments across CA — which companies pay providers there.
